ARTICLE | Company News

Eli Lilly management changes

September 29, 2017 10:57 PM UTC

Eli Lilly and Co. (NYSE:LLY) announced several managerial changes on Friday, including the promotion of SVP of Clinical and Product Development Dan Skovronsky to SVP for science and technology and president of Lilly Research Labs to replace Jan Lundberg effective June 1, 2018.

Skovronsky joined Lilly in 2010 when the pharma acquired Avid Radiopharmaceuticals Inc. (see BioCentury, Oct. 29, 2007 and Nov. 15, 2010)...